---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-006497"
form_type: "8-K"
ticker: "BFRI"
cik: "0001858685"
company_name: "Biofrontera Inc."
filed_at: "2023-03-02T23:59:59+00:00"
generated_at: "2026-06-18T16:15:10.597902+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Biofrontera receives Nasdaq non-compliance notice for bid price below $1.00 per share

## Summary
- Nasdaq notified Biofrontera on Feb 24, 2023, that common stock bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 days, until Aug 23, 2023, to regain compliance by achieving $1.00 closing bid for 10 consecutive days.
- If not cured, Biofrontera may qualify for a second 180-day period by meeting other listing standards and effecting a reverse stock split.
- No immediate impact on trading; delisting possible if compliance not regained.
- Company intends to monitor bid price and consider available options; no assurance of regaining compliance.

## SEC filing metadata
- accession: 0001493152-23-006497
- form_type: 8-K
- ticker: BFRI
- cik: 0001858685
- company_name: Biofrontera Inc.
- filed_at: 2023-03-02T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858685/000149315223006497/0001493152-23-006497-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858685/000149315223006497/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-006497
- JSON: https://secwatch.observer/filing/0001493152-23-006497.json
- Plain text: https://secwatch.observer/filing/0001493152-23-006497.txt

## Key facts
- Listing & Compliance Notices
  Biofrontera Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: February 24, 2023, Biofrontera Inc., a Delaware corporation (the “Company”), received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the listing of its common stock was not in compliance with Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market, as the closing bid price of the Company’s common stock was less than $1.00 per share for the previous 30 consecutive business days. The notice has no present impact on the listing or trading of the Company’s securities on The Nasdaq Capital Market. Un
  evidence_url: https://www.sec.gov/Archives/edgar/data/1858685/000149315223006497/0001493152-23-006497-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.